Literature DB >> 10196124

A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.

K Decanniere1, A Desmyter, M Lauwereys, M A Ghahroudi, S Muyldermans, L Wyns.   

Abstract

BACKGROUND: Camelid serum contains a large fraction of functional heavy-chain antibodies - homodimers of heavy chains without light chains. The variable domains of these heavy-chain antibodies (VHH) have a long complementarity determining region 3 (CDR3) loop that compensates for the absence of the antigen-binding loops of the variable light chains (VL). In the case of the VHH fragment cAb-Lys3, part of the 24 amino acid long CDR3 loop protrudes from the antigen-binding surface and inserts into the active-site cleft of its antigen, rendering cAb-Lys3 a competitive enzyme inhibitor.
RESULTS: A dromedary VHH with specificity for bovine RNase A, cAb-RN05, has a short CDR3 loop of 12 amino acids and is not a competitive enzyme inhibitor. The structure of the cAb-RN05-RNase A complex has been solved at 2.8 A. The VHH scaffold architecture is close to that of a human VH (variable heavy chain). The structure of the antigen-binding hypervariable 1 loop (H1) of both cAb-RN05 and cAb-Lys3 differ from the known canonical structures; in addition these H1 loops resemble each other. The CDR3 provides an antigen-binding surface and shields the face of the domain that interacts with VL in conventional antibodies.
CONCLUSIONS: VHHs adopt the common immunoglobulin fold of variable domains, but the antigen-binding loops deviate from the predicted canonical structure. We define a new canonical structure for the H1 loop of immunoglobulins, with cAb-RN05 and cAb-Lys3 as reference structures. This new loop structure might also occur in human or mouse VH domains. Surprisingly, only two loops are involved in antigen recognition; the CDR2 does not participate. Nevertheless, the antigen binding occurs with nanomolar affinities because of a preferential usage of mainchain atoms for antigen interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196124     DOI: 10.1016/s0969-2126(99)80049-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  41 in total

1.  Single-domain antibody fragments with high conformational stability.

Authors:  Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon G J Frenken; Serge Muyldermans; Lode Wyns; Andre Matagne
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Structural and thermodynamic analysis of the GFP:GFP-nanobody complex.

Authors:  Marta H Kubala; Oleksiy Kovtun; Kirill Alexandrov; Brett M Collins
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

3.  Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.

Authors:  C Anders Olson; Richard W Roberts
Journal:  Protein Sci       Date:  2007-03       Impact factor: 6.725

4.  Exploring the capacity of minimalist protein interfaces: interface energetics and affinity maturation to picomolar KD of a single-domain antibody with a flat paratope.

Authors:  Akiko Koide; Valentina Tereshko; Serdar Uysal; Katrina Margalef; Anthony A Kossiakoff; Shohei Koide
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

5.  High-affinity single-domain binding proteins with a binary-code interface.

Authors:  Akiko Koide; Ryan N Gilbreth; Kaori Esaki; Valentina Tereshko; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

6.  High affinity anti-inorganic material antibody generation by integrating graft and evolution technologies: potential of antibodies as biointerface molecules.

Authors:  Takamitsu Hattori; Mitsuo Umetsu; Takeshi Nakanishi; Takanari Togashi; Nozomi Yokoo; Hiroya Abe; Satoshi Ohara; Tadafumi Adschiri; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

7.  Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.

Authors:  Valentina Tereshko; Serdar Uysal; Akiko Koide; Katrina Margalef; Shohei Koide; Anthony A Kossiakoff
Journal:  Protein Sci       Date:  2008-04-29       Impact factor: 6.725

8.  An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.

Authors:  Sean W Fanning; James R Horn
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

9.  Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus.

Authors:  L P Daley; M A Kutzler; B W Bennett; M C Smith; A L Glaser; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2009-12-02

10.  Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.

Authors:  Erwin De Genst; Karen Silence; Klaas Decanniere; Katja Conrath; Remy Loris; Jörg Kinne; Serge Muyldermans; Lode Wyns
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.